CREATIVE REALITIES INC (CREX) Fundamental Analysis & Valuation

NASDAQ:CREX • US22530J3095

Current stock price

3.6 USD
-0.01 (-0.28%)
Last:

This CREX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. CREX Profitability Analysis

1.1 Basic Checks

  • CREX had positive earnings in the past year.
  • In the past year CREX has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: CREX reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: CREX reported negative operating cash flow in multiple years.
CREX Yearly Net Income VS EBIT VS OCF VS FCFCREX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

1.2 Ratios

  • CREX's Return On Assets of -14.93% is on the low side compared to the rest of the industry. CREX is outperformed by 65.22% of its industry peers.
  • CREX has a Return On Equity of -41.80%. This is comparable to the rest of the industry: CREX outperforms 42.39% of its industry peers.
Industry RankSector Rank
ROA -14.93%
ROE -41.8%
ROIC N/A
ROA(3y)-2.23%
ROA(5y)-17.47%
ROE(3y)-5.54%
ROE(5y)-80.4%
ROIC(3y)N/A
ROIC(5y)N/A
CREX Yearly ROA, ROE, ROICCREX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

  • Looking at the Gross Margin, with a value of 43.13%, CREX is in line with its industry, outperforming 54.35% of the companies in the same industry.
  • CREX's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for CREX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.36%
GM growth 5Y1.66%
CREX Yearly Profit, Operating, Gross MarginsCREX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. CREX Health Analysis

2.1 Basic Checks

  • CREX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, CREX has more shares outstanding
  • Compared to 5 years ago, CREX has more shares outstanding
  • CREX has a worse debt/assets ratio than last year.
CREX Yearly Shares OutstandingCREX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CREX Yearly Total Debt VS Total AssetsCREX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of 0.35, we must say that CREX is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.35, CREX is doing worse than 61.96% of the companies in the same industry.
  • CREX has a Debt/Equity ratio of 1.01. This is a high value indicating a heavy dependency on external financing.
  • CREX has a Debt to Equity ratio (1.01) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF N/A
Altman-Z 0.35
ROIC/WACCN/A
WACC8.17%
CREX Yearly LT Debt VS Equity VS FCFCREX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

  • CREX has a Current Ratio of 1.03. This is a normal value and indicates that CREX is financially healthy and should not expect problems in meeting its short term obligations.
  • CREX has a worse Current ratio (1.03) than 61.96% of its industry peers.
  • CREX has a Quick Ratio of 1.03. This is a bad value and indicates that CREX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.77, CREX is not doing good in the industry: 68.48% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 0.77
CREX Yearly Current Assets VS Current LiabilitesCREX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CREX Growth Analysis

3.1 Past

  • The earnings per share for CREX have decreased by 0.00% in the last year.
  • CREX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -18.37%.
  • Measured over the past years, CREX shows a quite strong growth in Revenue. The Revenue has been growing by 9.98% on average per year.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2100%
Revenue 1Y (TTM)-18.37%
Revenue growth 3Y40.23%
Revenue growth 5Y9.98%
Sales Q2Q%-26.97%

3.2 Future

  • The Earnings Per Share is expected to grow by 66.98% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 32.68% on average over the next years. This is a very strong growth
EPS Next Y-91.64%
EPS Next 2Y66.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.75%
Revenue Next 2Y42.62%
Revenue Next 3Y32.68%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CREX Yearly Revenue VS EstimatesCREX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
CREX Yearly EPS VS EstimatesCREX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

3

4. CREX Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 25.71, the valuation of CREX can be described as expensive.
  • Based on the Price/Earnings ratio, CREX is valued a bit cheaper than 70.65% of the companies in the same industry.
  • CREX is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.61, which is the current average of the S&P500 Index.
  • CREX is valuated correctly with a Price/Forward Earnings ratio of 13.84.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CREX indicates a somewhat cheap valuation: CREX is cheaper than 61.96% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.79. CREX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 25.71
Fwd PE 13.84
CREX Price Earnings VS Forward Price EarningsCREX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 61.96% of the companies in the same industry are cheaper than CREX, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 219.64
CREX Per share dataCREX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CREX's earnings are expected to grow with 66.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y66.98%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CREX Dividend Analysis

5.1 Amount

  • CREX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CREX Fundamentals: All Metrics, Ratios and Statistics

CREATIVE REALITIES INC

NASDAQ:CREX (3/25/2026, 8:19:23 PM)

3.6

-0.01 (-0.28%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)03-12
Earnings (Next)05-12
Inst Owners9.68%
Inst Owner Change10.7%
Ins Owners5.59%
Ins Owner Change0%
Market Cap84.60M
Revenue(TTM)44.32M
Net Income(TTM)-9.15M
Analysts84
Price Target8.29 (130.28%)
Short Float %0.55%
Short Ratio1.51
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-116.19%
Min EPS beat(2)-149.99%
Max EPS beat(2)-82.4%
EPS beat(4)1
Avg EPS beat(4)57.24%
Min EPS beat(4)-149.99%
Max EPS beat(4)601.45%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.37%
Min Revenue beat(2)-6.96%
Max Revenue beat(2)6.23%
Revenue beat(4)2
Avg Revenue beat(4)-2%
Min Revenue beat(4)-11.52%
Max Revenue beat(4)6.23%
Revenue beat(8)4
Avg Revenue beat(8)-2.2%
Revenue beat(12)4
Avg Revenue beat(12)-4.14%
Revenue beat(16)4
Avg Revenue beat(16)-3.48%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)3.13%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 25.71
Fwd PE 13.84
P/S 1.91
P/FCF N/A
P/OCF N/A
P/B 3.86
P/tB N/A
EV/EBITDA 219.64
EPS(TTM)0.14
EY3.89%
EPS(NY)0.26
Fwd EY7.23%
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS1.89
BVpS0.93
TBVpS-0.85
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.71
Profitability
Industry RankSector Rank
ROA -14.93%
ROE -41.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.13%
FCFM N/A
ROA(3y)-2.23%
ROA(5y)-17.47%
ROE(3y)-5.54%
ROE(5y)-80.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.36%
GM growth 5Y1.66%
F-Score2
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF N/A
Debt/EBITDA 46.08
Cap/Depr 51.44%
Cap/Sales 5.58%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 0.77
Altman-Z 0.35
F-Score2
WACC8.17%
ROIC/WACCN/A
Cap/Depr(3y)115.1%
Cap/Depr(5y)95.1%
Cap/Sales(3y)8.11%
Cap/Sales(5y)6.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2100%
EPS Next Y-91.64%
EPS Next 2Y66.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.37%
Revenue growth 3Y40.23%
Revenue growth 5Y9.98%
Sales Q2Q%-26.97%
Revenue Next Year10.75%
Revenue Next 2Y42.62%
Revenue Next 3Y32.68%
Revenue Next 5YN/A
EBIT growth 1Y-219.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year484.05%
EBIT Next 3Y202.07%
EBIT Next 5YN/A
FCF growth 1Y-208.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-125.48%
OCF growth 3Y93.04%
OCF growth 5YN/A

CREATIVE REALITIES INC / CREX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CREATIVE REALITIES INC?

ChartMill assigns a fundamental rating of 2 / 10 to CREX.


Can you provide the valuation status for CREATIVE REALITIES INC?

ChartMill assigns a valuation rating of 3 / 10 to CREATIVE REALITIES INC (CREX). This can be considered as Overvalued.


What is the profitability of CREX stock?

CREATIVE REALITIES INC (CREX) has a profitability rating of 2 / 10.


What are the PE and PB ratios of CREATIVE REALITIES INC (CREX) stock?

The Price/Earnings (PE) ratio for CREATIVE REALITIES INC (CREX) is 25.71 and the Price/Book (PB) ratio is 3.86.